Clinical Trial Update: Buprenorphine to Improve HIV Care Engagement and Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial investigating buprenorphine to improve HIV care engagement and outcomes; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Substance-related Disorders

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Oregon Health and Science University | Conditions: HIV, Substance Related Disorders | Phase 4 | Status: COMPLETED | Results posted: 2020-06-24